PMN310 is a humanized monoclonal antibody (mAb) designed and developed to selectively target only soluble amyloid-beta ...

ProMIS Neurosciences (PMN) announced important progress in the PRECISE-AD Phase 1b clinical trial with the dosing of multiple patients with its ...

The UV-curable coatings market is witnessing significant expansion, driven by the increasing demand for environmentally friendly coatings across various industries, including automotive, electronics, ...

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that ...

John joined ORNL as Distinguished R&D staff for Biological Systems and is currently leading the Soft Matter Sample Environments effort in Neutron Scattering Division. John has a broad academic ...

Entrada Therapeutics' innovative Endosomal Escape Vehicle platform, poised to revolutionize drug delivery. Click here to read ...

After hours: February 21 at 4:37:13 PM EST Loading Chart for PMN ...

为解决阿尔茨海默病（AD）发病机制不明及治疗难题，吉林大学研究人员开展 T3DM 与神经元代谢重编程研究。结果揭示相关机制并提出治疗策略，这为 AD 研究与治疗提供新思路，极具科研价值，推荐科研人员阅读。

After hours: February 21 at 4:37:13 p.m. EST ...